|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOW FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Discontinued operations, net | |||||
| Depreciation, depletion and amortization of assets | |||||
| Deferred income tax provision (benefit) | |||||
| Other noncash charges to income | |||||
| Asset impairments | |||||
| Losses (gains) on sales of assets and other, net | |||||
| Undistributed losses (earnings) from equity investments | |||||
| Dry hole expense | |||||
| Changes in operating assets and liabilities: | |||||
| (Increase) decrease in trade receivables | |||||
| (Increase) decrease in inventories | |||||
| Increase in other current assets | |||||
| (Increase) decrease in joint interest receivables and other current assets | |||||
| Decrease in accounts payable and accrued liabilities | |||||
| Increase (decrease) in current domestic and foreign income taxes | |||||
| Operating cash flow from continuing operations | |||||
| Operating cash flow from discontinued operations | |||||
| Net cash provided by operating activities | |||||
| CASH FLOW FROM INVESTING ACTIVITIES | |||||
| Capital expenditures | |||||
| Change in capital accrual | |||||
| Purchases of assets, businesses and equity investments, net | |||||
| Proceeds from sale of assets and equity investments, net | |||||
| Equity investments and other, net | |||||
| Investing cash flow from continuing operations | |||||
| Investing cash flow from discontinued operations | |||||
| Net cash used by investing activities | |||||
| CASH FLOW FROM FINANCING ACTIVITIES | |||||
| Draws on receivables securitization facility | |||||
| Total draws on receivables securitization facility | |||||
| Payment of receivables securitization facility | |||||
| Total payment of receivables securitization facility | |||||
| Debt issuance costs | |||||
| Proceeds from long-term debt, net | |||||
| Payments of long-term debt, net | |||||
| Total payments of long-term debt, net | |||||
| Redemption of preferred stock | |||||
| Purchases of treasury stock | |||||
| Cash dividends paid on common and preferred stock | |||||
| Proceeds from issuance of common stock | |||||
| Contributions from noncontrolling interest | |||||
| Financing portion of net cash paid for derivative instruments | |||||
| Deferred payments for purchases of assets and businesses | |||||
| Other financing, net | |||||
| Financing cash flow from continuing operations | |||||
| Financing cash flow from discontinued operations | |||||
| Net cash provided (used) by financing activities | |||||
| Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | |||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of year | |||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents — end of year | |||||
| CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS BALANCES FROM: | |||||
| Continuing operations - beginning of year | |||||
| Discontinued operations - beginning of year | |||||
| Less: discontinued operations - end of year | |||||
| Continuing operations - end of year | |||||
Loading...